Cognition Therapeutics (CGTX)
(Delayed Data from NSDQ)
$0.52 USD
-0.06 (-10.20%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $0.52 0.00 (-0.10%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | -0.19 |
EPS Last Quarter | -0.18 |
Last EPS Surprise | 18.18% |
ABR | 1.40 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.87 |
Next Year | -0.92 |
EPS (TTM) | -0.94 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.19 | -0.20 | -0.87 | -0.92 |
# of Estimates | 3 | 3 | 4 | 3 |
Most Recent Consensus | -0.16 | -0.14 | -0.72 | -0.32 |
High Estimate | -0.11 | -0.12 | -0.58 | -0.32 |
Low Estimate | -0.31 | -0.35 | -1.19 | -1.76 |
Year ago EPS | -0.22 | -0.27 | -0.86 | -0.87 |
Year over Year Growth Est. | 13.64% | 25.93% | -1.16% | -5.94% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 2 | 2 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.19 | -0.20 | -0.87 | -0.92 |
7 Days Ago | -0.19 | -0.20 | -0.87 | -0.92 |
30 Days Ago | -0.19 | -0.20 | -0.92 | -0.92 |
60 Days Ago | -0.22 | -0.23 | -0.97 | -1.20 |
90 Days Ago | -0.22 | -0.23 | -0.97 | -1.20 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.19 | -0.20 | -0.87 | -0.92 |
Zacks Consensus Estimate | -0.19 | -0.20 | -0.87 | -0.92 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.18 | -0.27 | -0.27 | -0.22 | NA |
Estimate | -0.22 | -0.23 | -0.38 | -0.31 | NA |
Difference | 0.04 | -0.04 | 0.11 | 0.09 | 0.05 |
Surprise | 18.18% | -17.39% | 28.95% | 29.03% | 14.69% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more